Preferred Label : Temozolomide;

MeSH definition : A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.;

MeSH synonym : 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; Methazolastone;

MeSH hyponym : TMZA-HE; CCRG-81045; CCRG81045; TMZ Bioshuttle; NSC-362856; NSC362856; M&B-39831; M&B39831;

MeSH Related Number : 85622-93-1 (Temozolomide);

Wikipedia link : https://en.wikipedia.org/wiki/Temozolomide;

UNII : YF1K15M17Y;

Details


Main resources

You can consult :

A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.

https://www.has-sante.fr/jcms/p_3536194/fr/kimozo-temozolomide-neuroblastome-chez-l-enfant
2024
false
false
false
France
infant
administration, oral
pharmaceutical solutions
treatment outcome
insurance, health, reimbursement
antineoplastic agents, alkylating
temozolomide
evaluation of the transparency committee
neuroblastoma
child
Childhood Neuroblastoma
Temozolomide

---
https://www.has-sante.fr/jcms/p_3448072/fr/kimozo-temozolomide-neuroblastome-chez-l-enfant
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
antineoplastic combined chemotherapy protocols
infant
administration, oral
antineoplastic agents, alkylating
temozolomide
High Risk Neuroblastoma
Refractory Neuroblastoma
Recurrent Neuroblastoma
evaluation of the transparency committee
neuroblastoma
child
Temozolomide

---
https://ansm.sante.fr/tableau-acces-derogatoire/kimozo-40-mg-ml-suspension-buvable#
2023
false
false
false
France
French
administration, oral
antineoplastic agents, alkylating
Temozolomide
child
neuroblastoma
summary of product characteristics
package leaflet
guidelines for drug use
Refractory Neuroblastoma
Recurrent Neuroblastoma
High Risk Neuroblastoma
glioblastoma multiforme
anaplastic astrocytoma
Recurrent Childhood Anaplastic Astrocytoma
Refractory Anaplastic Astrocytoma
medulloblastoma
Recurrent Childhood Medulloblastoma
Refractory Medulloblastoma
sarcoma, ewing
Recurrent Ewing Sarcoma
Refractory Ewing Sarcoma
rhabdomyosarcoma
Recurrent Childhood Rhabdomyosarcoma
Refractory Childhood Rhabdomyosarcoma

---
https://www.has-sante.fr/jcms/p_3329593/fr/kimozo-temozolomide
https://www.has-sante.fr/jcms/p_3329601/fr/decision-n-2022-0108/dc/sem-du-31-mars-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-kimozo
2022
false
false
false
France
evaluation of the transparency committee
Temozolomide

---
http://www.lecrat.eu/?s=T%C3%A9mozolomide+-+exposition+paternelle
France
drug information
pregnancy, high-risk
paternal exposure
teratogens
pregnancy, nos
Temozolomide

---
http://www.has-sante.fr/portail/jcms/c_2566809/fr/temozolomide-accord
2015
false
false
false
France
French
evaluation of the transparency committee
dacarbazine
Temozolomide

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39335a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39337a-fra.php
2014
Canada
French
English
temozolomide
antineoplastic agents, alkylating
Chemical and Drug Induced Liver Injury
continuity of patient care
drug monitoring
pharmacovigilance note
dacarbazine
Temozolomide

---
http://www.has-sante.fr/portail/jcms/c_1701806/fr/temozolomide-mylan
http://www.has-sante.fr/portail/upload/docs/evamed/CT-13082_TEMOZOLOMIDE_MYLAN_QDINS_Avis1_CT13082.pdf
2013
France
French
evaluation of the transparency committee
dacarbazine
temozolomide
antineoplastic agents, alkylating
administration, oral
adult
child
adolescent
glioblastoma
glioblastoma multiforme
neoplasm recurrence, local
anaplastic astrocytoma
astrocytoma
disease progression
drugs, generic
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63337988
2013
summary of product characteristics
capsules
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60862607
2013
summary of product characteristics
capsules
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69020770
2013
summary of product characteristics
capsules
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60858338
2013
summary of product characteristics
capsules
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=65421470
2013
summary of product characteristics
capsules
Temozolomide

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=67597823
2013
summary of product characteristics
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67992884
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62899458
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66368889
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62930074
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67082976
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66612044
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62665366
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61864867
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65304442
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61710965
2012
France
summary of product characteristics
package leaflet
powders
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68196114
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68740943
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66746278
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66186993
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62730650
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64990230
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67632968
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67246258
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61111403
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68674984
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63751409
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65009043
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60138073
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63263630
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temodal
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
adolescent
child
brain neoplasms
drug evaluation
treatment outcome
dacarbazine
antineoplastic agents, alkylating
glioma
antineoplastic agents, alkylating
antineoplastic agents, alkylating
pregnancy
breast feeding
glioblastoma
adult
temozolomide
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69573276
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63855589
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60024931
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62529302
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60691017
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68440390
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64643856
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63538165
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67119741
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67442641
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65988104
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62537701
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62935096
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62913872
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60822915
2012
France
summary of product characteristics
package leaflet
capsules
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temozolomide-Sun
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug approval
treatment outcome
administration, oral
drugs, generic
antineoplastic agents, alkylating
antineoplastic agents, alkylating
dacarbazine
temozolomide
glioblastoma
astrocytoma
astrocytoma, anaplastic
adult
child
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
Temozolomide
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temozolomide-Hexal
2012
United Kingdom
English
French
syndication feed
dacarbazine
antineoplastic agents, alkylating
antineoplastic agents, alkylating
temozolomide
glioblastoma
drug approval
drug labeling
treatment outcome
administration, oral
adult
child
adolescent
aged
drugs, generic
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
neoplasm recurrence, local
brain neoplasms
drug evaluation
summary of product characteristics
package leaflet
Temozolomide
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temozolomide-Sandoz
2012
United Kingdom
English
French
syndication feed
brain neoplasms
antineoplastic agents, alkylating
antineoplastic agents, alkylating
drug approval
drug labeling
treatment outcome
drugs, generic
administration, oral
adult
child
adolescent
glioblastoma
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dacarbazine
temozolomide
neoplasm recurrence, local
summary of product characteristics
package leaflet
drug evaluation
Temozolomide
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temomedac
2012
United Kingdom
French
English
syndication feed
dacarbazine
temozolomide
antineoplastic agents, alkylating
antineoplastic agents, alkylating
administration, oral
drugs, generic
brain neoplasms
astrocytoma
glioblastoma
neoplasm recurrence, local
adult
child
adolescent
aged
drug approval
drug labeling
treatment outcome
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
drug evaluation
package leaflet
Temozolomide
Temozolomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Temozolomide-Teva
2012
United Kingdom
French
English
syndication feed
dacarbazine
antineoplastic agents, alkylating
temozolomide
antineoplastic agents, alkylating
drug approval
drug labeling
treatment outcome
administration, oral
drugs, generic
adult
child
adolescent
glioblastoma
astrocytoma
brain neoplasms
aged
drug interactions
pregnancy
breast feeding
neoplasm recurrence, local
drug evaluation, preclinical
package leaflet
drug evaluation
summary of product characteristics
Temozolomide
Temozolomide

---
http://www.cochrane.org/fr/CD007415
2010
false
true
false
France
United Kingdom
dacarbazine
treatment outcome
review of literature
french abstract
glioma
Temozolomide

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4A/6D/resume.phtml
2009
France
French
child
aged
dacarbazine
antineoplastic agents, alkylating
glioma
brain neoplasms
temozolomide
consensus
guidelines for drug use
journal article
Temozolomide

---
http://medecine-pharmacie.univ-rouen.fr/servlet/com.univ.collaboratif.utils.LectureFichiergw?ID_FICHIER=12641
2005
false
true
false
false
France
glioblastoma
critical appraisal or critical reading
glioblastoma
dacarbazine
Temozolomide

---
http://medecine-pharmacie.univ-rouen.fr/servlet/com.univ.collaboratif.utils.LectureFichiergw?ID_FICHIER=12642
2005
false
true
false
false
France
educational course
glioblastoma
dacarbazine
Temozolomide

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-T%C3%A9molozomide_et_gliomes_malins_(2005-11).pdf
2005
false
false
Canada
French
survival rate
antineoplastic agents, alkylating
glioblastoma
brain neoplasms
bibliography of medicine
chemotherapy, adjuvant
glioblastoma
glioblastoma
antineoplastic agents, alkylating
quebec
glioblastoma
brain neoplasms
brain neoplasms
temozolomide
dacarbazine
guidelines for drug use
Temozolomide

---
Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.